Results 161 to 170 of about 7,401,341 (346)

Design and experiment of a novel intelligent device suitable for automation vegetable plug seedling. [PDF]

PLoS One
Haifei Q, Zhike N, Xiandong C, Bo L, Yifan Z, Feiyang L, Jiajun Z.   +6 more
europepmc   +1 more source

Social cohesion as a real-life phenomenon: assessing the explanatory power of the universalist and particularist perspectives [PDF]

, 2011
A Green, A Green, A Kearns, A Smolar, Council of Europe, D Cramer, E Durkheim, F Rajulton, G Esping Andersen, G Schoepflin, GA Almond, H Kohn, H Kohn, J Chan, J Moody, Jan Germen Janmaat, JG Janmaat, K Deutsch, K Newton, LW Pye, M Crepaz, M Mann, N Letki, R Bellah, R Bendix, R Brubaker, R Inglehart, R Inglehart, R Inglehart, R Putnam, R Rose, R Rose, RA Dahl, RJ Dalton, S Huntington, T Parsons, W Hutton, W Rostow, World Bank   +38 more
core   +2 more sources

An Out‐of‐Place Etiology: Recognizing FMR1 Premutation in the Memory Clinic

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The FMR1 gene premutation (55–200 CGG repeats) is usually associated with a wide range of symptoms and phenotypes within the Fragile X‐tremor/ataxia syndrome (FXTAS), but may also manifest as predominant or isolated cognitive decline. We describe three male patients referred for progressive cognitive impairment and behavioral changes. Standard
Guido Greco, Caterina Motta, Enrica Marchionni, Maria Rosaria D'Apice, Carlangelo Carrese, Giuseppe Novelli, Alessandro Martorana, Chiara Giuseppina Bonomi   +7 more
wiley   +1 more source

Study on the effect of modified Liu-an decoction on Th1/Th2 function in Guinea pigs with cough variant asthma through the Notch signal pathway. [PDF]

PLoS One
Xu F, Deng J, Zhang N, Leow KX, Li P, Lu C, Chen Y, Zhang Y, Wu L.   +8 more
europepmc   +1 more source

Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein, Maximilian Mönch, Meret Herdick, Frauke Stascheit, Sarah Hoffmann, Hannah Preßler, Philipp Mergenthaler, Carla Dusemund, Paolo Doksani, Haoqi Sun, Pushpa Narayanaswami, Andreas Meisel, Lea Gerischer, Sophie Lehnerer   +13 more
wiley   +1 more source

Community Strengthening in Urban Neighborhoods: Psychosocial Dynamics in Vulnerable Contexts. [PDF]

J Community Psychol
Constanzo AZ, Trujillo V, Ojeda MG, Mella FR.   +3 more
europepmc   +1 more source

Martine Mazaudon. Phonologie tamang: étude phonologique du dialecte tamang de Risiangku [PDF]

, 1975
Sprigg, R. K.
core   +1 more source

Variably Protease‐Sensitive Prionopathy: Two New Cases With Motor Neuron‐Dementia Syndrome

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT We describe two patients with variably protease‐sensitive prionopathy (VPSPr) who developed progressive upper motor neuron symptoms, insomnia, behavioral and cognitive decline, compatible with primary lateral sclerosis associated with frontotemporal dementia (FTD).
María Elena Erro, María Victoria Zelaya, Hasier Eraña, Javier Sánchez Ruiz de Gordoa, Fermín García‐Amigot, Anika Simonovska‐Serra, María Cristina Caballero, Isidre Ferrer, Ellen Gelpi, Ivonne Jericó, Joaquín Castilla   +10 more
wiley   +1 more source

Investigating the Discoloration of Leaves of Dioscorea polystachya Using Developed Atomic Absorption Spectrometry Methods for Manganese and Molybdenum. [PDF]

Molecules
Krüger D, Weng A, Baecker D.
europepmc   +1 more source

Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The practice of neurology requires an understanding of clinical ethics for decision‐making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision‐making around selection of a disease‐modifying therapy (DMT), risks and benefits of well‐studied medications in comparison to
Methma Udawatta, Farrah J. Mateen
wiley   +1 more source